For more information about Bedfont's stance on Coronavirus and breath testing, click here.
A fractional exhaled nitric oxide (FeNO) breath testing monitor to measure airway inflammation and improve asthma management.
The NObreath® has been recommended by NICE to measure FeNO and aid in diagnosing asthma, in adults and children, as well as monitoring and managing asthma symptoms of patients.
Using FeNO measurements to evaluate airway inflammation in asthma represents a significant advance in respiratory medicine2, but until now it has been an expensive test to deliver in everyday practice. Recommended by NICE4 and conformed to ERS/ATS guidelines5, the NObreath® FeNO monitor is the essential tool for asthma.
Features and benefits include:
*Subject to servicing and general wear and tear
Integrating a FeNO monitor into your patient pathway shouldn’t come at a high price; the NObreath® FeNO monitor price is tailored to your usage levels and we are confident we can beat or reduce your alternative/current FeNO monitor cost. To find out the NObreath® FeNO monitor price and ongoing cost in your area please contact one of our local distributors by clicking ‘Request A Quote’ below.
Request A QuoteYears of research and vigorous testing ensures our Bedfont® products and consumables are not only safe for consumer use, but compliant with Medical Device Regulations. Use of counterfeit or non-Bedfont® approved accessories and consumables may result in loss of performance and/or damage to your device. This risk of incorrect results could adversely affect patient care. We also remind you that counterfeit and/or non-Bedfont® accessories and consumables do not possess the quality and reliability of the original manufacturer products, nor have they undergone the Toxicology tests to ensure they are fit to be used orally, and therefore their safety and infection control efficacy cannot be guaranteed.
Specifically designed with the latest integrated infection control filter which removes and traps >99% of airborne bacteria and >96% of viruses from the patient's breath. These can be used up to 3 times per patient, dramatically reducing the cost of testing for FeNo.
Concentration range(CO)(Mouthpiece) | 5-300ppb |
---|---|
Display | Colour LCD touchscreen |
Detection principle | Electrochemical sensor |
Repeatability | ±5ppb/±10% of measured value - whichever is greater* |
Accuracy | ±5ppb/±10% of measured value - whichever is greater* |
Power | 3 x AA (LR6 or equivalent) - up to 120 tests; 2 x CR2032 Lithium coin cell |
T90 response time | <10; seconds |
Operating temperature | 10-30°C |
Storage/transport temperature | 10-30°C |
Operating/storage/transport pressure | Atmospheric ±10% |
Operating humidity | 10-75% non-condensing |
Storage/transport humidity | 25-80% non-condensing |
Sensor operating life | 5 years** |
Sensor sensitivity | 5ppb |
Sensor drift | <5% per annum |
Dimensions | Approx. 152 x 87 x 47mm |
Weight | Approx. 400g (including batteries) |
Materials | Case: polycarbonate/ABS blend with elastomeric overmould; NObreathFLO™: polycarbonate/ABS blend; Mouthpiece: polypropylene |
CO cross-interference | 45ppm≤17.6ppb |
Breath test time | Adult 12 seconds; child 10 seconds |
Warm-up time | <60 seconds |
Ambient air test | 30 seconds |
Maximum ambient operating level | 350ppb NO |
*Readings of ≥200ppb at temperatures between 20-30°C can decrease accuracy to ±15% of measured value. **Subject to servicing. |
The latest literature for the NObreath® Monitor.
If you would like more information or would like to purchase one of our monitors please get in touch with us via our request a quote page. We will try our best to get back to you as soon as we can.